These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1991821)

  • 1. Interleukin-6 is elevated in plasma in multiple sclerosis.
    Frei K; Fredrikson S; Fontana A; Link H
    J Neuroimmunol; 1991 Feb; 31(2):147-53. PubMed ID: 1991821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-2 secreting cells in multiple sclerosis and controls.
    Lu CZ; Fredrikson S; Xiao BG; Link H
    J Neurol Sci; 1993 Dec; 120(1):99-106. PubMed ID: 8289087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal production of neopterin in aseptic meningo-encephalitis and multiple sclerosis.
    Fredrikson S; Eneroth P; Link H
    Clin Exp Immunol; 1987 Jan; 67(1):76-81. PubMed ID: 3621676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased interleukin-6 mRNA expression in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis.
    Navikas V; Matusevicius D; Söderström M; Fredrikson S; Kivisäkk P; Ljungdahl A; Höjeberg B; Link H
    J Neuroimmunol; 1996 Jan; 64(1):63-9. PubMed ID: 8598391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.
    Horellou P; Wang M; Keo V; Chrétien P; Serguera C; Waters P; Deiva K
    J Neuroimmunol; 2015 Dec; 289():1-7. PubMed ID: 26616865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis.
    Rentzos M; Cambouri C; Rombos A; Nikolaou C; Anagnostouli M; Tsoutsou A; Dimitrakopoulos A; Triantafyllou N; Vassilopoulos D
    J Neurol Sci; 2006 Feb; 241(1-2):25-9. PubMed ID: 16316662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal synthesis of beta-2-microglobulin in multiple sclerosis and aseptic meningo-encephalitis.
    Us O; Lolli F; Baig S; Link H
    Acta Neurol Scand; 1989 Dec; 80(6):598-602. PubMed ID: 2694730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-15 mRNA expression is up-regulated in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis (MS).
    Kivisäkk P; Matusevicius D; He B; Söderström M; Fredrikson S; Link H
    Clin Exp Immunol; 1998 Jan; 111(1):193-7. PubMed ID: 9472681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-12 and perforin mRNA expression is augmented in blood mononuclear cells in multiple sclerosis.
    Matusevicius D; Kivisäkk P; Navikas V; Söderström M; Fredrikson S; Link H
    Scand J Immunol; 1998 Jun; 47(6):582-90. PubMed ID: 9652827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-6 concentration in serum and cerebrospinal fluid in multiple sclerosis patients.
    Stelmasiak Z; Kozioł-Montewka M; Dobosz B; Rejdak K; Bartosik-Psujek H; Mitosek-Szewczyk K; Belniak-Legieć E
    Med Sci Monit; 2000; 6(6):1104-8. PubMed ID: 11208463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple sclerosis is associated with an imbalance between tumour necrosis factor-alpha (TNF-alpha)- and IL-10-secreting blood cells that is corrected by interferon-beta (IFN-beta) treatment.
    Ozenci V; Kouwenhoven M; Huang YM; Kivisäkk P; Link H
    Clin Exp Immunol; 2000 Apr; 120(1):147-53. PubMed ID: 10759776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune activation in multiple sclerosis: study of IL-2, sIL-2R, and gamma-IFN levels in serum and cerebrospinal fluid.
    Gallo P; Piccinno MG; Pagni S; Argentiero V; Giometto B; Bozza F; Tavolato B
    J Neurol Sci; 1989 Aug; 92(1):9-15. PubMed ID: 2504888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-6 and sIL-6R concentration in the cerebrospinal fluid and serum of MS patients.
    Stelmasiak Z; Kozioł-Montewka M; Dobosz B; Rejdak K
    Med Sci Monit; 2001; 7(5):914-8. PubMed ID: 11535934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal damage and neuroinflammation markers in patients with autoimmune encephalitis and multiple sclerosis.
    Fominykh V; Brylev L; Gaskin V; Luzin R; Yakovlev A; Komoltsev I; Belousova I; Rosliakova A; Guekht A; Gulyaeva N
    Metab Brain Dis; 2019 Oct; 34(5):1473-1485. PubMed ID: 31267347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
    Mouzaki A; Rodi M; Dimisianos N; Emmanuil A; Kalavrizioti D; Lagoudaki R; Grigoriadis NC; Papathanasopoulos P
    PLoS One; 2015; 10(8):e0135434. PubMed ID: 26317430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approach to discriminate subgroups in multiple sclerosis with cerebrospinal fluid (CSF) basic inflammation indices and TNF-alpha, IL-1beta, IL-6, IL-8.
    Kleine TO; Zwerenz P; Graser C; Zöfel P
    Brain Res Bull; 2003 Aug; 61(3):327-46. PubMed ID: 12909303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor-alfa and interleukin-4 in cerbrospinal fluid and plasma in different clinical forms of multiple sclerosis.
    Obradović D; Kataranovski M; Dincić E; Obradović S; Colić M
    Vojnosanit Pregl; 2012 Feb; 69(2):151-6. PubMed ID: 22500369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Terminal component of complement C9 in CSF and plasma of patients with MS and aseptic meningitis.
    Halawa I; Lolli F; Link H
    Acta Neurol Scand; 1989 Aug; 80(2):130-5. PubMed ID: 2816275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple sclerosis is associated with enhanced B cell responses to the ganglioside GD1a.
    Matà S; Lolli F; Söderström M; Pinto F; Link H
    Mult Scler; 1999 Dec; 5(6):379-88. PubMed ID: 10618693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated cerebrospinal fluid adiponectin and adipsin levels in patients with multiple sclerosis: a Finnish co-twin study.
    Hietaharju A; Kuusisto H; Nieminen R; Vuolteenaho K; Elovaara I; Moilanen E
    Eur J Neurol; 2010 Feb; 17(2):332-4. PubMed ID: 19538214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.